BioNTech SE BNTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/14/21 EDT
190.21quote price arrow down-2.56 (-1.33%)
Volume
27,752
Close
192.77quote price arrow up+11.98 (+6.63%)
Volume
2,918,735
52 week range
45.08 - 213.15

...

Loading . . .
  • Open183.49
  • Day High194.77
  • Day Low181.56
  • Prev Close180.79
  • 52 Week High213.15
  • 52 Week High Date05/04/21
  • 52 Week Low45.08
  • 52 Week Low Date05/14/20

Key Stats

  • Market Cap46.558B
  • Shares Out241.52M
  • 10 Day Average Volume6.31M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change136.47

KEY STATS

  • Open183.49
  • Day High194.77
  • Day Low181.56
  • Prev Close180.79
  • 52 Week High213.15
  • 52 Week High Date05/04/21
  • 52 Week Low45.08
  • 52 Week Low Date05/14/20
  • Market Cap46.558B
  • Shares Out241.52M
  • 10 Day Average Volume6.31M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change136.47

RATIOS/PROFITABILITY

  • EPS (TTM)5.04
  • P/E (TTM)38.25
  • Fwd P/E (NTM)6.04
  • EBITDA (MRQ)2.032B
  • ROE (MRQ)80.65%
  • Revenue (MRQ)3.023B
  • Gross Margin (MRQ)88.55%
  • Net Margin (MRQ)47.81%
  • Debt To Equity (MRQ)26.07%

EVENTS

  • Earnings Date08/12/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
381.03+7.58+2.03%
SGEN
Seagen Inc
147.50+2.79+1.93%
MRNA
Moderna Inc
161.38+11.51+7.68%
GMAB
Genmab A/S
37.08+0.38+1.04%
INCY
Incyte Corp
82.62-0.61-0.73%